Loading…
Rodents infected with Schistosoma mansoni produce cytolytic IgG and IgM antibodies to the Lewis x antigen
Schistosoma mansoni is a blood fluke that produces glyco-conjugates containing the Lewis x antigen (Lex) Galβ1→4(Fucα1→3) GlcNAcβ1→R. However, Lex antigen is also normally expressed in many tissues of adult rodents. We now report that mice and hamsters chronically infected with S.mansoni generate hi...
Saved in:
Published in: | Glycobiology (Oxford) 1997-03, Vol.7 (2), p.207-215 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Schistosoma mansoni is a blood fluke that produces glyco-conjugates containing the Lewis x antigen (Lex) Galβ1→4(Fucα1→3) GlcNAcβ1→R. However, Lex antigen is also normally expressed in many tissues of adult rodents. We now report that mice and hamsters chronically infected with S.mansoni generate high titers of both IgM and IgG antibodies reactive with Lex and that no reactivity is present in sera from uninfected animals. Anti-Lex antibodies were detected by ELISA using the Lex-containing neoglycoprotein lacto-N-fucopentaoseIII-BSA. The IgG in infected animals consists of IgG1, IgG2a, and IgG2b subclasses and binds to Protein A-Sepharose. The sera of infected animals reacts only with Lex antigen and has no reactivity toward either Lex or sialyl Lex. The IgM response to Lex is detectable at week 2, whereas the IgG response is detectable at weeks 5–6 following infection of mice. The sera of infected mice and hamsters can mediate the complement-dependent cytolysis (CDC) of cells expressing surface Lex. This cytolytic activity is exclusively effected by the anti-Lex antibodies, since their removal from sera by adsorption depletes the sera of CDC activity. Thus, the abundant expression of the Lex antigens by the parasite elicits cytolytic antibodies reactive with a host antigen. |
---|---|
ISSN: | 0959-6658 1460-2423 |
DOI: | 10.1093/glycob/7.2.207 |